Report cover image

Global Antibiotics and Antimycotics Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 194 Pages
SKU # APRC20284022

Description

Summary

According to APO Research, The global Antibiotics and Antimycotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antibiotics and Antimycotics include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Pfizer, GSK, Bayer and AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibiotics and Antimycotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Antibiotics and Antimycotics, also provides the sales of main regions and countries. Of the upcoming market potential for Antibiotics and Antimycotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibiotics and Antimycotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antibiotics and Antimycotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antibiotics and Antimycotics sales, projected growth trends, production technology, application and end-user industry.

Antibiotics and Antimycotics Segment by Company

Sanofi
Johnson & Johnson
Novartis
Merck
Roche
Pfizer
GSK
Bayer
AbbVie
AstraZeneca
Eli Lilly
Antibiotics and Antimycotics Segment by Type

Aminoglycosides
Macrolides
Sulfonamides
Quinolones (Fluoroquinolones)
Penicillins
Tetracyclines
Carbapenems
Cephalosporins
Other
Antibiotics and Antimycotics Segment by Application

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Antibiotics and Antimycotics Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics and Antimycotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and Antimycotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics and Antimycotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Antibiotics and Antimycotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Antibiotics and Antimycotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibiotics and Antimycotics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Antibiotics and Antimycotics Market by Type
1.2.1 Global Antibiotics and Antimycotics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Aminoglycosides
1.2.3 Macrolides
1.2.4 Sulfonamides
1.2.5 Quinolones (Fluoroquinolones)
1.2.6 Penicillins
1.2.7 Tetracyclines
1.2.8 Carbapenems
1.2.9 Cephalosporins
1.2.10 Other
1.3 Antibiotics and Antimycotics Market by Application
1.3.1 Global Antibiotics and Antimycotics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Antibiotics and Antimycotics Market Dynamics
2.1 Antibiotics and Antimycotics Industry Trends
2.2 Antibiotics and Antimycotics Industry Drivers
2.3 Antibiotics and Antimycotics Industry Opportunities and Challenges
2.4 Antibiotics and Antimycotics Industry Restraints
3 Global Market Growth Prospects
3.1 Global Antibiotics and Antimycotics Revenue Estimates and Forecasts (2020-2031)
3.2 Global Antibiotics and Antimycotics Revenue by Region
3.2.1 Global Antibiotics and Antimycotics Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Antibiotics and Antimycotics Revenue by Region (2020-2025)
3.2.3 Global Antibiotics and Antimycotics Revenue by Region (2026-2031)
3.2.4 Global Antibiotics and Antimycotics Revenue Market Share by Region (2020-2031)
3.3 Global Antibiotics and Antimycotics Sales Estimates and Forecasts 2020-2031
3.4 Global Antibiotics and Antimycotics Sales by Region
3.4.1 Global Antibiotics and Antimycotics Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Antibiotics and Antimycotics Sales by Region (2020-2025)
3.4.3 Global Antibiotics and Antimycotics Sales by Region (2026-2031)
3.4.4 Global Antibiotics and Antimycotics Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Antibiotics and Antimycotics Revenue by Manufacturers
4.1.1 Global Antibiotics and Antimycotics Revenue by Manufacturers (2020-2025)
4.1.2 Global Antibiotics and Antimycotics Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Antibiotics and Antimycotics Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Antibiotics and Antimycotics Sales by Manufacturers
4.2.1 Global Antibiotics and Antimycotics Sales by Manufacturers (2020-2025)
4.2.2 Global Antibiotics and Antimycotics Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Antibiotics and Antimycotics Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Antibiotics and Antimycotics Sales Price by Manufacturers (2020-2025)
4.4 Global Antibiotics and Antimycotics Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Antibiotics and Antimycotics Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Antibiotics and Antimycotics Manufacturers, Product Type & Application
4.7 Global Antibiotics and Antimycotics Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Antibiotics and Antimycotics Market CR5 and HHI
4.8.2 2024 Antibiotics and Antimycotics Tier 1, Tier 2, and Tier 3
5 Antibiotics and Antimycotics Market by Type
5.1 Global Antibiotics and Antimycotics Revenue by Type
5.1.1 Global Antibiotics and Antimycotics Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Antibiotics and Antimycotics Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Antibiotics and Antimycotics Revenue Market Share by Type (2020-2031)
5.2 Global Antibiotics and Antimycotics Sales by Type
5.2.1 Global Antibiotics and Antimycotics Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Antibiotics and Antimycotics Sales by Type (2020-2031) & (K Tons)
5.2.3 Global Antibiotics and Antimycotics Sales Market Share by Type (2020-2031)
5.3 Global Antibiotics and Antimycotics Price by Type
6 Antibiotics and Antimycotics Market by Application
6.1 Global Antibiotics and Antimycotics Revenue by Application
6.1.1 Global Antibiotics and Antimycotics Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Antibiotics and Antimycotics Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Antibiotics and Antimycotics Revenue Market Share by Application (2020-2031)
6.2 Global Antibiotics and Antimycotics Sales by Application
6.2.1 Global Antibiotics and Antimycotics Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Antibiotics and Antimycotics Sales by Application (2020-2031) & (K Tons)
6.2.3 Global Antibiotics and Antimycotics Sales Market Share by Application (2020-2031)
6.3 Global Antibiotics and Antimycotics Price by Application
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Sanofi Antibiotics and Antimycotics Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Comapny Information
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Johnson & Johnson Antibiotics and Antimycotics Product Portfolio
7.2.5 Johnson & Johnson Recent Developments
7.3 Novartis
7.3.1 Novartis Comapny Information
7.3.2 Novartis Business Overview
7.3.3 Novartis Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Novartis Antibiotics and Antimycotics Product Portfolio
7.3.5 Novartis Recent Developments
7.4 Merck
7.4.1 Merck Comapny Information
7.4.2 Merck Business Overview
7.4.3 Merck Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merck Antibiotics and Antimycotics Product Portfolio
7.4.5 Merck Recent Developments
7.5 Roche
7.5.1 Roche Comapny Information
7.5.2 Roche Business Overview
7.5.3 Roche Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Roche Antibiotics and Antimycotics Product Portfolio
7.5.5 Roche Recent Developments
7.6 Pfizer
7.6.1 Pfizer Comapny Information
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pfizer Antibiotics and Antimycotics Product Portfolio
7.6.5 Pfizer Recent Developments
7.7 GSK
7.7.1 GSK Comapny Information
7.7.2 GSK Business Overview
7.7.3 GSK Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 GSK Antibiotics and Antimycotics Product Portfolio
7.7.5 GSK Recent Developments
7.8 Bayer
7.8.1 Bayer Comapny Information
7.8.2 Bayer Business Overview
7.8.3 Bayer Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Bayer Antibiotics and Antimycotics Product Portfolio
7.8.5 Bayer Recent Developments
7.9 AbbVie
7.9.1 AbbVie Comapny Information
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 AbbVie Antibiotics and Antimycotics Product Portfolio
7.9.5 AbbVie Recent Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Comapny Information
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 AstraZeneca Antibiotics and Antimycotics Product Portfolio
7.10.5 AstraZeneca Recent Developments
7.11 Eli Lilly
7.11.1 Eli Lilly Comapny Information
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Antibiotics and Antimycotics Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Eli Lilly Antibiotics and Antimycotics Product Portfolio
7.11.5 Eli Lilly Recent Developments
8 North America
8.1 North America Antibiotics and Antimycotics Market Size by Type
8.1.1 North America Antibiotics and Antimycotics Revenue by Type (2020-2031)
8.1.2 North America Antibiotics and Antimycotics Sales by Type (2020-2031)
8.1.3 North America Antibiotics and Antimycotics Price by Type (2020-2031)
8.2 North America Antibiotics and Antimycotics Market Size by Application
8.2.1 North America Antibiotics and Antimycotics Revenue by Application (2020-2031)
8.2.2 North America Antibiotics and Antimycotics Sales by Application (2020-2031)
8.2.3 North America Antibiotics and Antimycotics Price by Application (2020-2031)
8.3 North America Antibiotics and Antimycotics Market Size by Country
8.3.1 North America Antibiotics and Antimycotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Antibiotics and Antimycotics Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Antibiotics and Antimycotics Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Antibiotics and Antimycotics Market Size by Type
9.1.1 Europe Antibiotics and Antimycotics Revenue by Type (2020-2031)
9.1.2 Europe Antibiotics and Antimycotics Sales by Type (2020-2031)
9.1.3 Europe Antibiotics and Antimycotics Price by Type (2020-2031)
9.2 Europe Antibiotics and Antimycotics Market Size by Application
9.2.1 Europe Antibiotics and Antimycotics Revenue by Application (2020-2031)
9.2.2 Europe Antibiotics and Antimycotics Sales by Application (2020-2031)
9.2.3 Europe Antibiotics and Antimycotics Price by Application (2020-2031)
9.3 Europe Antibiotics and Antimycotics Market Size by Country
9.3.1 Europe Antibiotics and Antimycotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Antibiotics and Antimycotics Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Antibiotics and Antimycotics Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Antibiotics and Antimycotics Market Size by Type
10.1.1 China Antibiotics and Antimycotics Revenue by Type (2020-2031)
10.1.2 China Antibiotics and Antimycotics Sales by Type (2020-2031)
10.1.3 China Antibiotics and Antimycotics Price by Type (2020-2031)
10.2 China Antibiotics and Antimycotics Market Size by Application
10.2.1 China Antibiotics and Antimycotics Revenue by Application (2020-2031)
10.2.2 China Antibiotics and Antimycotics Sales by Application (2020-2031)
10.2.3 China Antibiotics and Antimycotics Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Antibiotics and Antimycotics Market Size by Type
11.1.1 Asia Antibiotics and Antimycotics Revenue by Type (2020-2031)
11.1.2 Asia Antibiotics and Antimycotics Sales by Type (2020-2031)
11.1.3 Asia Antibiotics and Antimycotics Price by Type (2020-2031)
11.2 Asia Antibiotics and Antimycotics Market Size by Application
11.2.1 Asia Antibiotics and Antimycotics Revenue by Application (2020-2031)
11.2.2 Asia Antibiotics and Antimycotics Sales by Application (2020-2031)
11.2.3 Asia Antibiotics and Antimycotics Price by Application (2020-2031)
11.3 Asia Antibiotics and Antimycotics Market Size by Country
11.3.1 Asia Antibiotics and Antimycotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Antibiotics and Antimycotics Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Antibiotics and Antimycotics Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Antibiotics and Antimycotics Market Size by Type
12.1.1 SAMEA Antibiotics and Antimycotics Revenue by Type (2020-2031)
12.1.2 SAMEA Antibiotics and Antimycotics Sales by Type (2020-2031)
12.1.3 SAMEA Antibiotics and Antimycotics Price by Type (2020-2031)
12.2 SAMEA Antibiotics and Antimycotics Market Size by Application
12.2.1 SAMEA Antibiotics and Antimycotics Revenue by Application (2020-2031)
12.2.2 SAMEA Antibiotics and Antimycotics Sales by Application (2020-2031)
12.2.3 SAMEA Antibiotics and Antimycotics Price by Application (2020-2031)
12.3 SAMEA Antibiotics and Antimycotics Market Size by Country
12.3.1 SAMEA Antibiotics and Antimycotics Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Antibiotics and Antimycotics Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Antibiotics and Antimycotics Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Antibiotics and Antimycotics Value Chain Analysis
13.1.1 Antibiotics and Antimycotics Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Antibiotics and Antimycotics Production Mode & Process
13.2 Antibiotics and Antimycotics Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Antibiotics and Antimycotics Distributors
13.2.3 Antibiotics and Antimycotics Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.